Status:
RECRUITING
Treatment of Central Airway Stenoses Using Computer-Assisted Customized 3d Stents TATUM
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Airway Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Airway stenting is usually efficient to treat central airway obstruction but can lead to severe and potentially lethal complications (stent migration, obstructive granuloma, perforation, and hemoptysi...
Eligibility Criteria
Inclusion
- Age \>18 years
- Informed consent
- Complex, proximal and symptomatic (dyspnea, cough, peak flow \< 50%, FEV1 \< 50% or post-stenotic infection) airway stenosis
Exclusion
- Acute respiratory distress, mechanical ventilation
- Contraindication to rigid bronchoscopy (severe and irreversible coagulation disorders)
- Pregnancy
Key Trial Info
Start Date :
June 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04848025
Start Date
June 17 2021
End Date
December 1 2025
Last Update
November 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Toulouse
Toulouse, Toulouse, France, 31000